Brief Report

Proactive Bias Mitigation When Using Online Survey Panels for Self-Reported Use of Illicitly Manufactured Fentanyl in the General Adult Population

JAMA Health Forum 10.1001/jamahealthforum.2025.4011

November 07, 2025 at 11:00 AM EST

Read the full article

How much does proactive bias mitigation affect prevalence estimates of illicitly manufactured fentanyl use when using an online general population survey?In this survey study including 175 058 respondents, the 2024 estimate of illicitly manufactured fentanyl use decreased from 3.9% to 1.1% after bias mitigation, a 70.9% drop. Bias-mitigated estimates of oral use of illicitly manufactured fentanyl increased from 35.9% in 2022 to 44.4% in 2024, which was the most common route of administration.When using online surveys, proactive bias mitigation is essential to produce valid estimates.

Corresponding Author: Joshua C. Black, PhD, Rocky Mountain Poison joshua.black@rmpds.org).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2025.4011?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=110725

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks